GENETIC AND ENVIRONMENTAL RISK FACTORS IN ATOPIC DERMATITIS
GENETIC AND ENVIRONMENTAL RISK FACTORS IN ATOPIC DERMATITIS
批准号:
7607293
负责人:
LYNDA C SCHNEIDER
金额:
$1.81万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31
关键词:
AffectAgeAllergic rhinitisAsthmaAtopic DermatitisChildChildhoodChronicClinicalComputer Retrieval of Information on Scientific Projects DatabaseConditionDataDevelopmentDiagnosisDiseaseEnvironmental Risk FactorFood HypersensitivityFundingGenesGeneticGenetic PolymorphismGoalsGrantIncidenceInstitutionParticipantPathogenesisPediatric HospitalsPhenotypePhysical ExaminationRecording of previous eventsResearchResearch PersonnelResourcesSourceUnited States National Institutes of Healthbasegene environment interactiongenetic risk factornovelskin disorder
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Atopic dermatitis (AD) is the most common chronic skin disorder of childhood. The majority of children with atopic dermatitis develop other atopic diseases including food allergy, allergic rhinitis and asthma. The diagnosis of AD is largely based upon clinical history and physical examination and improvement of the condition can be seen as one ages. The incidence of this disorder is increasing and is estimated to affect over 10% of children worldwide. Currently at Children's Hospital, approximately 12,000 children with AD are followed who present mostly at a very young age. Furthermore, there is a strong genetic as well as environmental component contributing to the pathogenesis of AD.
The overall goals of this study include phenotyping participants with AD followed at Children's Hospital, identifying polymorphisms in known and novel genes that may be associated with this condition and investigating environmental and genetic risk factors predisposing to the development of AD. Ultimately, the data collected from this study will allow us to pursue other hypotheses, and to look for gene-environment interactions, in the development of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNE RESPONSE TO VARICELLA VACCINATION IN SUBJECTS WITH ATOPIC DERMATITIS
-
批准号:7607299
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2007
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
GENETICS OF ATOPIC DERMATITIS - ECZEMA HERPETICUM (ADEH) STUDY
-
批准号:7607301
-
项目类别:
-
资助金额:$0.58万
-
财政年份:2007
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
ADVN BIOMARKER REGISTRY STUDY
-
批准号:7607300
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2007
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
EDEMA2:EVALUATION OF DX-88'S EFFECTS IN MITIGATING ANGIOEDEMA, AN OPEN LABEL STD
-
批准号:7380738
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2006
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
DX-88 IN HEREDITARY ANGIOEDEMA
-
批准号:7204698
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
EDEMA2:EVALUATION OF DX-88'S EFFECTS IN MITIGATING ANGIOEDEMA, AN OPEN LABEL STD
-
批准号:7204720
-
项目类别:
-
资助金额:$3.85万
-
财政年份:2005
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
EDEMA2:Evaluation of DX-88's Effects In Mitigating Angioedema, An Open Label Std
-
批准号:6975195
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2004
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
DX-88 in Hereditary Angioedema
-
批准号:6975172
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2004
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
OPEN LABEL EXTENSION TO A STUDY OF FOUR DOSE REGIMENS OF BUDESONIDE
-
批准号:6120802
-
项目类别:
-
资助金额:$3.04万
-
财政年份:1998
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
STUDY OF BUDESONIDE NEBULIZING SUSPENSION & PLACEBO IN ASTHMATIC CHILDREN
-
批准号:6120788
-
项目类别:
-
资助金额:$3.04万
-
财政年份:1998
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
STUDY OF BUDESONIDE NEBULIZING SUSPENSION & PLACEBO IN ASTHMATIC CHILDREN
-
批准号:6251912
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
OPEN LABEL EXTENSION TO A STUDY OF FOUR DOSE REGIMENS OF BUDESONIDE
-
批准号:6251935
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
OPEN LABEL EXTENSION TO A STUDY OF FOUR DOSE REGIMENS OF BUDESONIDE
-
批准号:6281421
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
STUDY OF BUDESONIDE NEBULIZING SUSPENSION & PLACEBO IN ASTHMATIC CHILDREN
-
批准号:6281407
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:LYNDA C SCHNEIDER
-
依托单位:
TRIAL OF NEBULIZED BUDESONIDE FOR MODERATE ASTHMA IN CHILDREN
-
批准号:5223817
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LYNDA C SCHNEIDER
-
依托单位:--
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: